估计GFR误差对心力衰竭患者的影响和后果
Pablo Jorge-Pérez1, Martín J García-González1, Marta M Martín-Cabeza1
1Acute Cardiovascular Care Unit, Cardiology Department, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain.
Scientific reports
|October 29, 2024
概括
测量膜过率 (mGFR) 准确预测急性心力衰竭 (AHF) 患者的心血管事件,与估计的GFR (eGFR) 公式不同. 这项研究强调了AHF精确功能评估对改善患者结果的临床重要性.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 心脏病学 心脏病学
- 临床医学 临床医学
背景情况:
- 急性心力衰竭 (AHF) 是一种普遍存在的疾病,其再入院率很高.
- 在AHF患者中,降低功能与增加的死亡率有关.
- 准确的功能评估对于管理AHF患者至关重要.
研究的目的:
- 为了比较测量膜过率 (mGFR) 与估计的GFR (eGFR) 对AHF患者心血管 (CV) 结果的影响.
- 评估各种eGFR公式与AHF群体中的mGFR的准确性和一致性.
- 为了确定mGFR或eGFR是否更好地预测AHF的未来CV事件.
主要方法:
- 涉及90名AHF患者的前性研究.
- 测量GFR (mGFR) 通过iohexol-dbs.的血清除来确定.
- 使用Cockcroft-Gault,MDRD,CKD-EPI肌素,CKD-EPI囊素-C,以及组合CKD-EPI方程计算的eGFR.
- 用于评估CV结果的Cox生存分析.
主要成果:
- 在mGFR和eGFR之间适度一致 (一致性相关系数=0.77).
- mGFR,但不是eGFR,与心血管事件有显著的关联 (p=0.037;HR=0.98).
- 其他CV事件的重要预测因素包括NTproBNP,BMI,LVEF和先前的冠状动脉疾病.
结论:
- 在AHF患者中,eGFR公式中的错误是实质性的和随机的.
- mGFR是AHF未来CV事件的重要预测因素,而eGFR不是.
- 不准确的eGFR可能对AHF患者的管理产生重大临床后果.
相关概念视频
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
01:22Heart Failure Drugs: Diuretics
346
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
346
01:29Heart Failure II: Pathophysiology
1
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1
01:17Factors Affecting Renal Clearance: Renal Impairment
58
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
58
01:27Heart Failure I: Introduction
1
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
394
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
394